n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ab, O; Audette, CA; Chari, RV; Doherty, H; Erickson, HK; Goldmacher, VS; Johnson, H; Jones, GE; Kellogg, B; Kovtun, YV; Lai, KC; Lutz, RJ; Maloney, EK; Mayo, MF; Pinkas, J; Singh, R; Sun, X; Widdison, WC; Wilhelm, S | 1 |
1 other study(ies) available for n-(4-carboxycyclohexylmethyl)maleimide n-hydroxysuccinimide ester and Colonic Neoplasms
Article | Year |
---|---|
Antibody-maytansinoid conjugates designed to bypass multidrug resistance.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Renal Cell; Cell Adhesion Molecules; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epithelial Cell Adhesion Molecule; Female; Humans; Immunotoxins; Kidney Neoplasms; Maleimides; Maytansine; Mice; Mice, SCID; Polyethylene Glycols | 2010 |